US Military’s Synthetic Blood R&D: A Proxy for War Economy’s Enduring Biopolitical Gamble and the Erasure of Trauma-Informed Care
Original framing: “The US military’s race to make fake blood” — MIT Technology Review
The US military’s synthetic blood R&D is part of a long history of militarized bioengineering, from World War II’s *plasma fractionation programs* (which repurposed civilian blood banks for soldiers) to the 1990s *DARPA-funded hemoglobin-based oxygen carriers* (HBOCs) that failed in clinical trials but were later revived for military use. This pattern reveals how war economies *preemptively* redirect medical research toward combat efficiency, often at the expense of civilian healthcare. The 2003 *Iraq War* also saw the military’s *Blood Program*, which prioritized logistical chains over individual patient outcomes—a precedent for today’s synthetic blood initiatives. The narrative omits how these historical precedents set the stage for today’s biopolitical calculus, where soldiers’ lives are treated as variables in a war machine.
Text: The US military’s synthetic blood R&D is not an isolated technological pursuit but a *microcosm of how war economies distort life itself*—treating soldiers’ bodies as variables in a logistical machine rather than sacred or communal goods.
This narrative obscures the *historical pattern* of militarized bioengineering, where innovations like synthetic blood are repurposed to sustain prolonged conflict, diverting resources from trauma-informed care and civilian healthcare. The framing also erases *cross-cultural* perspectives, where blood is understood as a *relational* and *spiritual* substance tied to collective identity, not a problem to be solved through engineering. By focusing on *technical feasibility* alone, the story ignores the *scientific risks* of HBOCs (toxicity, instability) and the *marginalized voices* of veterans and global South medical practitioners who offer alternative pathways. A *trickster* reading reveals the absurdity of pretending synthetic blood is a neutral solution—it is, in fact, a *distraction* that avoids confronting the root causes of war (imperialism, resource extraction). The solution lies not in more militarized innovation, but in *decolonizing R&D*, redirecting funds to trauma care, and integrating Indigenous knowledge into healing frameworks. The US military’s synthetic blood project is a symptom of a broader *biopolitical crisis*—one where life is treated as a resource to be extracted, rather than a trust to be nurtured.